Sales decline 76.25% to Rs 26.61 crore
Net Loss of Parabolic Drugs reported to Rs 288.59 crore in the quarter ended March 2015 as against net loss of Rs 61.01 crore during the previous quarter ended March 2014. Sales declined 76.25% to Rs 26.61 crore in the quarter ended March 2015 as against Rs 112.05 crore during the previous quarter ended March 2014.For the full year,net loss reported to Rs 379.32 crore in the year ended March 2015 as against net loss of Rs 131.74 crore during the previous year ended March 2014. Sales declined 46.84% to Rs 228.78 crore in the year ended March 2015 as against Rs 430.38 crore during the previous year ended March 2014.
ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales26.61112.05 -76 228.78430.38 -47 OPM %-266.97-68.80 --33.81-16.00 - PBDT-113.93-100.64 -13 -176.03-151.94 -16 PBT-135.22-117.66 -15 -249.00-220.02 -13 NP-288.59-61.01 -373 -379.32-131.74 -188
Powered by Capital Market - Live News
